Autolus Therapeutics Plc ADR (AUTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2018 | 03-2018 | 09-2017 | |
| Sales | 443 | 426 | 0 |
| Gross Profit | 443 | 426 | N/A |
| Operating Expenses | 16,966 | 15,957 | 0 |
| Operating Income | -16,523 | -15,531 | N/A |
| Other Income | 6,656 | -2,652 | 0 |
| Pre-tax Income | -9,867 | -18,183 | 0 |
| Income Tax | -2,217 | -1,466 | N/A |
| Net Income Continuous | -7,650 | -16,717 | N/A |
| Net Income | $-7,650 | $-16,717 | $N/A |
| EPS Basic Total Ops | -0.26 | -0.58 | N/A |
| EPS Basic Continuous Ops | -0.26 | -0.58 | N/A |
| EPS Diluted Total Ops | -0.26 | -0.58 | N/A |
| EPS Diluted Continuous Ops | -0.26 | -0.58 | N/A |
| EBITDA(a) | $-16,005 | $-15,127 | $N/A |